Use of a Tumor-Cell Enrichment Column for the Enhanced Detection of Minimal Residual Disease in the BM or Apheresis Peripheral Blood Transplant Products of Breast-Cancer Patients

By Shammo JM   Smith SL   Bennett MV   Lee HW   Ostrander A   Ross AA   Williams SF  

Cytotherapy, Vol. 1, Iss. 5, 1999-01 ,pp. : 367-376

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sepsis, low platelet nadir at mobilization and previous IFN use predict stem cell mobilization failure in patients with multiple myeloma

By Putkonen M.   Rauhala A.   Pelliniemi T-T   Remes K.  

Cytotherapy, Vol. 9, Iss. 6, 2007-01 ,pp. : 548-554

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor

By Taubert Isabel   Saffrich Rainer   Zepeda-Moreno Abraham   Hellwig Isabelle   Eckstein Volker   Bruckner Thomas   Ho Anthony D.   Wuchter Patrick  

Cytotherapy, Vol. 13, Iss. 4, 2011-04 ,pp. : 459-466

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma

By Hiwase Dk   Hiwase S.   Bailey M.   Bollard G.   Schwarer Ap  

Cytotherapy, Vol. 10, Iss. 5, 2008-01 ,pp. : 507-517

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors

By McGuire TR   Kessinger A   Hock L   Sharp JG  

Cytotherapy, Vol. 3, Iss. 5, 2001-09 ,pp. : 361-364

Ashgate Publishing Ltd

Access to resources Recommend Favorite